TAILIEUCHUNG - Chapter 088. Hepatocellular Carcinoma (Part 7)

Chapter 088. Hepatocellular Carcinoma (Part 7) Local Injection Therapy Numerous agents have been used for local injection into tumors, most commonly, ethanol (PEI). The relatively soft HCC within the hard background of cirrhotic liver allows for injection of large volumes of ethanol into the tumor without diffusion into the hepatic parenchyma or leakage out of the liver. PEI causes direct destruction of cancer cells, but it is not selective for cancer cells and will destroy normal cells in the vicinity. It usually requires multiple injections (average of three), in contrast to one for RFA. The maximum size of tumor reliably treated. | Chapter 088. Hepatocellular Carcinoma Part 7 Local Injection Therapy Numerous agents have been used for local injection into tumors most commonly ethanol PEI . The relatively soft HCC within the hard background of cirrhotic liver allows for injection of large volumes of ethanol into the tumor without diffusion into the hepatic parenchyma or leakage out of the liver. PEI causes direct destruction of cancer cells but it is not selective for cancer cells and will destroy normal cells in the vicinity. It usually requires multiple injections average of three in contrast to one for RFA. The maximum size of tumor reliably treated is 3 cm even with multiple injections. Liver Transplantation A viable option for stages I and II tumors in the setting of cirrhosis is OLTX with survival approaching that for noncancer cases. OLTX for patients with a single lesion 5 cm or three or fewer nodules each 3 cm Milan criteria resulted in excellent tumor-free survival 70 at 5 years . For advanced HCC OLTX has been abandoned due to high tumor recurrence rates. Priority scoring for OLTX previously led to HCC patients waiting too long for their OLTX resulting in some tumors becoming too advanced during the patient s wait for a donated liver. A variety of therapies were used as a bridge to OLTX including RFA PEI and transarterial chemoembolization TACE . These pretransplant treatments allow patients to remain on the waiting list longer giving them greater opportunities to be transplanted. What remains unclear is whether this translates into prolonged survival after transplant. Further it is not known whether patients who have had their tumor s treated preoperatively follow the recurrence pattern predicted by their tumor status at the time of transplant . post local ablative therapy or if they follow the course set by their tumor parameters present before such treatment. The United Network for Organ Sharing UNOS point system for priority scoring of OLTX recipients now includes additional .

TỪ KHÓA LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.